In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
386 News Items found
How MSK Is Improving CAR-T Cell Therapy for Cancer Treatment
How MSK Is Improving CAR T Cell Therapy for Cancer Treatment

Learn how experts at MSK who helped develop CAR T cell therapy to fight cancer are making the treatment stronger, safer, more durable and accessible to more people.
fluorescent cells
Small Number of ‘Highly Plastic’ Cancer Cells Drive Disease Progression and Treatment Resistance

A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer progression and its ability to evolve resistance to treatment, MSK researchers have found in a laboratory study of lung cancer.
MSK Surgeon Aimee Crago
In the Clinic
How Research Is Driving the Latest Treatments for Sarcoma

Surgeon and researcher Aimee Crago discusses the latest treatments for different types of soft tissue sarcoma, including liposarcoma and desmoid tumors.
Valerie Rusch, Murray Brennan, Bob Li, Charles Rudin
Memorial Sloan Kettering and the Chinese Thoracic Oncology Group Discuss Opportunities for Further Collaboration to Accelerate International Clinical Trials During Annual Symposium

Building on their long-term shared commitment to international collaboration on cancer research and care – Memorial Sloan Kettering Cancer Center (MSK)...
Staff involved in implementing the new technology for diagnosing gene mutations in tumors include (from left) Marc Ladanyi, Angela Marchetti, Chris Lau, Laetitia Borsu, and Khedoudja Nafa.
New Technology Will Improve Molecular Testing of Tumors for Patients

Memorial Sloan Kettering has made an important step forward in efficiently diagnosing gene mutations in patients' cancers on an individual basis.
Scott Stuart and Dr. Selwyn Vickers stand side by side smiling.
A Message From the Chairman and President

Learn from the MSK President/CEO and Chair of the Board of Trustees about some of the most important advances in cancer care and science at MSK in 2024.
An illustration of lung develop alongside tumor evolution
In the Lab
Shape-Shifting Stem Cells Are Key to Cancer Metastasis and Immune Evasion

By assuming primitive regenerative identities, cancer cells gain the adaptability they need to establish tumors in new parts of the body.
Cody holds his graduation cap
Cody's Story: How the MSK Kids Rare Tumor Program Benefited a Teenager With Advanced Kidney Cancer 

Cody Bass was diagnosed with metastatic kidney cancer when he was 17. Two years later, he has no evidence of disease, thanks to a clinical trial at MSK.
Does Exercise Improve Survival After a Cancer Diagnosis? An Encouraging New Study

Learn how exercise can help many people live longer after they are diagnosed with cancer, according to a new study from MSK's Exercise-Oncology Service.
Lymphoma patient Symantha Wilson
Making Immunotherapy Work for More People

Symantha Wilson was crushed when chemotherapy quit fighting her lymphoma — and thrilled when immuno¬therapy beat back the cancer. But why doesn’t immunotherapy help more people? MSK researchers are finding answers.